Clint Tomlinson | Investor Relations |
Christopher Missling | President and Chief Executive Officer |
Sandra Boenisch | Principal Financial Officer |
Yun Zhong | Janney Capital |
Edward Marks | H.C. Wainwright |
Clayton Berger | Dawson James |
Tom Bishop | BI Research |
Anna Vorobyeva | ROTH Capital |
Welcome to the Anavex Life Sciences Fiscal 2019 Third Quarter Financial Results Conference Call.
As a reminder, this conference call is being recorded.
I will now like to introduce your host for today’s conference, Clint Tomlinson. Please go ahead.
Thank you, and good afternoon, everyone.